COVID-19 患者出院 3 个月随访时一氧化碳弥散功能异常
该研究对武汉 2020 年 1–2 月出院的 647 例 COVID-19 患者进行 3 个月前瞻性随访,发现乏力、心悸、呼吸困难症状在重症患者中更常见;81 例完成肺功能检查者中 54% 存在 D_LCO 异常,且与入院 CT 总严重度评分 >10.5 及 ARDS 相关。
要点
- COVID-19 出院 3 个月时 D_LCO 异常常见,重症者更明显。
- 入院 CT 总严重度评分 >10.5 与 D_LCO 受损独立相关。
- ARDS 发生与随访 D_LCO 异常相关。
核心结论
- COVID-19 幸存者出院 3 个月时肺功能尤其 D_LCO 下降,且与入院 CT 总严重度评分 >10.5 和 ARDS 发生相关。
- 肺间质损伤可能参与 D_LCO 异常的机制。
研究设计与样本
- 前瞻性随访研究,纳入武汉 2020 年 1–2 月出院 COVID-19 患者 647 例,随访 3 个月。
- 肺功能亚组共 81 例,其中非重症 41 例、重症 40 例。
主要发现
- 647 例中乏力 87 例(13%)、心悸 63 例(10%)、呼吸困难 56 例(9%)。
- 重症患者乏力 19% 对比非重症 10%(p=0.003),心悸 14% 对比 7%(p=0.007),呼吸困难 12% 对比 7%(p=0.014)。
- 多因素回归显示重症患者持续症状 OR 1.7(95%CI 1.1–2.6;p=0.026),住院时间较长者 OR 1.03(95%CI 1.00–1.05;p=0.041)。
- 肺功能亚组 44 例(54%)D_LCO 异常,重症 68% 对比非重症 42%(p=0.019)。
- 入院 CT 总严重度评分 >10.5(OR 10.4,95%CI 2.5–44.1;p=0.001)和 ARDS(OR 4.6,95%CI 1.4–15.5;p=0.014)与 D_LCO 受损相关。
临床怎么用
- COVID-19 出院患者随访应关注 D_LCO 等肺功能,尤其重症、住院时间长及入院 CT 严重度高者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate pulmonary function and clinical symptoms in coronavirus disease 2019 (COVID-19) survivors within 3 months after hospital discharge, and to identify risk factors associated with impaired lung function. METHODS AND MATERIAL: COVID-19 patients were prospectively followed-up with pulmonary function tests and clinical characteristics for 3 months following discharge from a hospital in Wuhan, China between January and February 2020. RESULTS: 647 patients were included. 87 (13%) patients presented with weakness, 63 (10%) with palpitations and 56 (9%) with dyspnoea. The prevalence of each of the three symptoms were markedly higher in severe patients than nonsevere patients (19% versus 10% for weakness, p=0.003; 14% versus 7% for palpitations, p=0.007; 12% versus 7% for dyspnoea, p=0.014). Results of multivariable regression showed increased odds of ongoing symptoms among severe patients (OR 1.7, 95% CI 1.1-2.6; p=0.026) or patients with longer hospital stays (OR 1.03, 95% CI 1.00-1.05; p=0.041). Pulmonary function test results were available for 81 patients, including 41 nonsevere and 40 severe patients. In this subgroup, 44 (54%) patients manifested abnormal diffusing capacity of the lung for carbon monoxide (D LCO) (68% severe versus 42% nonsevere patients, p=0.019). Chest computed tomography (CT) total severity score >10.5 (OR 10.4, 95% CI 2.5-44.1; p=0.001) on admission and acute respiratory distress syndrome (ARDS) (OR 4.6, 95% CI 1.4-15.5; p=0.014) were significantly associated with impaired D LCO. Pulmonary interstitial damage may be associated with abnormal D LCO. CONCLUSION: Pulmonary function, particularly D LCO, declined in COVID-19 survivors. This decrease was associated with total severity score of chest CT >10.5 and ARDS occurrence. Pulmonary interstitial damage might contribute to the imparied D LCO.
引用
- Qin W, Chen S, Zhang Y, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021. PMID: 33574077. doi:10.1183/13993003.03677-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。